These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19839997)

  • 1. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Hope S; Melle I; Aukrust P; Steen NE; Birkenaes AB; Lorentzen S; Agartz I; Ueland T; Andreassen OA
    Bipolar Disord; 2009 Nov; 11(7):726-34. PubMed ID: 19839997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.
    Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA
    Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Brietzke E; Teixeira AL
    Bipolar Disord; 2010 Jun; 12(4):453-4. PubMed ID: 20636645
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory evidence for the psychosis continuum model.
    Mørch RH; Dieset I; Færden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Psychoneuroendocrinology; 2016 May; 67():189-97. PubMed ID: 26923849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.
    Dieset I; Hope S; Ueland T; Bjella T; Agartz I; Melle I; Aukrust P; Røssberg JI; Andreassen OA
    Schizophr Res; 2012 Sep; 140(1-3):169-74. PubMed ID: 22817875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study.
    Mørch RH; Dieset I; Faerden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Haram M; Falk RS; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Acta Psychiatr Scand; 2017 Oct; 136(4):400-408. PubMed ID: 28815548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.
    Hope S; Hoseth E; Dieset I; Mørch RH; Aas M; Aukrust P; Djurovic S; Melle I; Ueland T; Agartz I; Ueland T; Westlye LT; Andreassen OA
    Schizophr Res; 2015 Jul; 165(2-3):188-94. PubMed ID: 25956633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljević M
    Psychiatr Danub; 2010 Jun; 22(2):275-7. PubMed ID: 20562761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.
    O'Brien SM; Scully P; Scott LV; Dinan TG
    J Affect Disord; 2006 Feb; 90(2-3):263-7. PubMed ID: 16410025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.
    O'Brien SM; Scully P; Dinan TG
    Psychiatry Res; 2008 Sep; 160(3):256-62. PubMed ID: 18722671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune variations in bipolar disorder: phasic differences.
    Ortiz-Domínguez A; Hernández ME; Berlanga C; Gutiérrez-Mora D; Moreno J; Heinze G; Pavón L
    Bipolar Disord; 2007 Sep; 9(6):596-602. PubMed ID: 17845274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.
    Orre IJ; Murison R; Dahl AA; Ueland T; Aukrust P; Fosså SD
    Brain Behav Immun; 2009 Aug; 23(6):868-74. PubMed ID: 19362138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.
    Brietzke E; Stertz L; Fernandes BS; Kauer-Sant'anna M; Mascarenhas M; Escosteguy Vargas A; Chies JA; Kapczinski F
    J Affect Disord; 2009 Aug; 116(3):214-7. PubMed ID: 19251324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.
    Tsai SY; Chung KH; Wu JY; Kuo CJ; Lee HC; Huang SH
    J Affect Disord; 2012 Jan; 136(1-2):110-116. PubMed ID: 21962564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.